The main findings of the study were that WT in patients with PAD improved walking capacity, promoted angiogenesis, and increased the muscular expression of VEGF and miRNA-126, enhancing the PI3K/Akt/eNOS angiogenic pathway. Here, VEGFA is linked to peripheral arterial disease.